The phrase ‘build it and they will come’ dates all the way back to the Old Testament, and in more...
Read more
HotSpot Therapeutics recently announced a strategic collaboration with AbbVie to develop IRF5 transcription factor inhibitors for autoimmune diseases. The following…
Read more
Immunotherapy has been the holy grail in the fight against cancer for the last decade. For good reason, we’ve been...
Read more
White Hat Hackers, sometimes called “ethical hackers,” are individuals that work to find and fix security problems in a system...
Read more
It is in moments like this that we are reminded of the collective power of good to overcome the disenfranchised…
Read more
No, your next doctor will not be a robot. Nor will an algorithm cure cancer. However, AI technology will absolutely...
Read more
The pharmaceutical industry still faces unrelenting challenges across the entirety of the drug development landscape. According to Piper Sandler’s recent...
Read more
Today marks an important point in our journey to patients as HotSpot Therapeutics announces its $100MM Series C financing. This infusion of…
Read more
Returning to work following the pandemic presents an opportunity to think creatively about how to re-configure the workplace
Read more
Today marks an important milestone for HotSpot Therapeutics as we announce our Series B financing, but it also marks a...
Read more